Skip to main content
Journal of Family Medicine and Primary Care logoLink to Journal of Family Medicine and Primary Care
letter
. 2017 Jul-Sep;6(3):693–694. doi: 10.4103/2249-4863.222050

Diagnostic criteria for drug rash and eosinophilia with systemic symptoms

Ashok Kumar Pannu 1,, Atul Saroch 2
PMCID: PMC5787987  PMID: 29417040

Dear Editor,

We found the paper by Jmeian et al. concerning a case of allopurinol-related drug rash with eosinophilia and systemic symptoms (DRESS) in a patient of chronic kidney disease and gout, interesting.[1] The presence of eosinophilia, the temporal relationship of the symptoms with the initiation of treatment with allopurinol, and the marked improvement on withdrawal of the drug along with the administration of systemic corticosteroids were features suggesting the diagnosis of DRESS.

DRESS is considered a severe drug reaction with a case fatality rate of 10–20%.[2] The diagnosis is sometimes difficult since the clinical manifestations may be incomplete or nonspecific, and it can also present as a purely systemic disease without any cutaneous involvement.[3,4]

Multiple diagnostic criteria have been developed and used to standardize the diagnosis and management of DRESS, albeit with limited success.

Bocquet et al. were the first who proposed criteria for DRESS [Table 1].[5] The Registry of Severe Cutaneous Adverse Reaction (RegiSCAR) group suggested criteria for hospitalized patients with a drug rash to diagnose DRESS syndrome [Table 2].[6] RegiSCAR constitutes a European RegiSCAR, including Stevens–Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, and DRESS. In an effort to define more accurately the DRESS syndrome, a scoring system has also been developed the RegiSCAR scoring system [Table 3].[6] A Japanese group suggested another set of diagnostic criteria; however, universal adaptation of this criteria may be limited since one of the criteria includes HHV-6 activation and some tests, such as measurement of IgG titer anti-HHV 6, are yet not routinely available [Table 4].[7]

Table 1.

Bocquet et al. proposed criteria for diagnosis of drug rash and eosinophilia with systemic symptoms/drug-induced hypersensitivity

graphic file with name JFMPC-6-693-g001.jpg

Table 2.

Registry of severe cutaneous adverse reaction criteria for diagnosis of drug rash and eosinophilia with systemic symptoms

graphic file with name JFMPC-6-693-g002.jpg

Table 3.

Registry of severe cutaneous adverse reaction diagnosis score for drug rash and eosinophilia with systemic symptoms

graphic file with name JFMPC-6-693-g003.jpg

Table 4.

Japanese group's criteria for diagnosis of drug rash and eosinophilia with systemic symptoms/drug-induced hypersensitivity

graphic file with name JFMPC-6-693-g004.jpg

DRESS is a challenging drug adverse reaction which can cause life-threatening organ dysfunction. Clinicians must be alert to this possibility to reach the correct diagnosis and institute the appropriate management.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  • 1.Jmeian A, Hawatmeh A, Shamoon R, Shamoon F, Guma M. Skin rash, eosinophilia, and renal impairment in a patient recently started on allopurinol. J Family Med Prim Care. 2016;5:479–81. doi: 10.4103/2249-4863.192366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kumari R, Timshina DK, Thappa DM. Drug hypersensitivity syndrome. Indian J Dermatol Venereol Leprol. 2011;77:7–15. doi: 10.4103/0378-6323.74964. [DOI] [PubMed] [Google Scholar]
  • 3.Sasidharanpillai S, Riyaz N, Rajan U, Binitha MP, Khader A, Mariyath OK, et al. Drug reaction with eosinophilia and systemic symptoms: Observations from a tertiary care institution. Indian J Dermatol Venereol Leprol. 2014;80:221–8. doi: 10.4103/0378-6323.132249. [DOI] [PubMed] [Google Scholar]
  • 4.Ben m’rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, et al. Drug-induced hypersensitivity syndrome: Clinical and biologic disease patterns in 24 patients. Medicine (Baltimore) 2009;88:131–40. doi: 10.1097/MD.0b013e3181a4d1a1. [DOI] [PubMed] [Google Scholar]
  • 5.Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) Semin Cutan Med Surg. 1996;15:250–7. doi: 10.1016/s1085-5629(96)80038-1. [DOI] [PubMed] [Google Scholar]
  • 6.Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: Does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609–11. doi: 10.1111/j.1365-2133.2006.07704.x. [DOI] [PubMed] [Google Scholar]
  • 7.Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083–4. doi: 10.1111/j.1365-2133.2007.07807.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Family Medicine and Primary Care are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES